Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-9042.
Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-9042; Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, INCT-Regenera, Rio de Janeiro, 21941-902, Brazil.
J Biol Chem. 2018 Jul 20;293(29):11388-11400. doi: 10.1074/jbc.RA117.001337. Epub 2018 Jun 5.
The role of albumin reabsorption in proximal tubule (PT) cells has emerged as an important factor in the genesis of albuminuria observed in the early stages of diabetes. Evidence has shown that a decrease in megalin expression could be the key mechanism in this process. In the present work, we investigated the molecular mechanism underlying the modulation of albumin endocytosis in LLC-PK1 cells, a model of PT cells. High glucose concentrations (HG) inhibited megalin expression and albumin endocytosis after 48 h of incubation. This inhibitory effect involves the entrance of glucose into PT cells through SGLT located at the luminal membrane. Once inside PT cells, glucose is diverted to the hexosamine biosynthetic pathway (HBP) increasing -GlcNAcylation of several intracellular proteins, including PKB. This process promotes the inhibition of PKB activity measured by its phosphorylation at Thr-308 and Ser-473 and phosphorylation of specific substrates, glycogen synthase kinase 3β (GSK3β) and tuberous sclerosis complex 2. The decrease in PKB activity led to a decrease in megalin expression and, consequently, reducing albumin endocytosis in LLC-PK1 cells. HG did not change mammalian target of rapamycin (mTOR) C2 activity, responsible for phosphorylated PKB at Ser-473. In addition, HG activated the mTORC1/S6K pathway, but this effect was not correlated to the decrease in megalin expression or albumin endocytosis. Taken together, our data help to clarify the current understanding underlying the genesis of tubular albuminuria induced by hyperglycemia in the early stage of diabetes pathogenesis.
白蛋白重吸收在近端肾小管 (PT) 细胞中的作用已成为糖尿病早期观察到白蛋白尿发生的一个重要因素。有证据表明,megalin 表达的减少可能是这一过程的关键机制。在本工作中,我们研究了 LLC-PK1 细胞(PT 细胞模型)中白蛋白内吞作用调节的分子机制。高葡萄糖浓度 (HG) 在孵育 48 小时后抑制 megalin 表达和白蛋白内吞作用。这种抑制作用涉及 SGLT 通过位于腔膜的葡萄糖进入 PT 细胞。一旦进入 PT 细胞,葡萄糖就会转向己糖胺生物合成途径 (HBP),增加包括 PKB 在内的几种细胞内蛋白的 -GlcNAc 化。这一过程促进了 PKB 活性的抑制,其通过 Thr-308 和 Ser-473 的磷酸化以及糖原合酶激酶 3β (GSK3β) 和结节性硬化复合物 2 的特定底物的磷酸化来测量。PKB 活性的降低导致 megalin 表达的减少,从而减少 LLC-PK1 细胞中的白蛋白内吞作用。HG 并没有改变负责 PKB 在 Ser-473 磷酸化的哺乳动物雷帕霉素靶蛋白 (mTOR) C2 活性。此外,HG 激活了 mTORC1/S6K 途径,但这种效应与 megalin 表达或白蛋白内吞作用的减少无关。总之,我们的数据有助于阐明糖尿病发病早期高血糖诱导的管状白蛋白尿发生的当前理解。